Safety Evaluation Ultimately Replacing Animal Testing (SEURAT-1)
Owner/Developer: European Commission and Cosmetics Europe
| Country: | Belgium |
|---|---|
| Languages: | English |
| Url: | http://www.seurat-1.eu/ |
| Contact: | http://www.seurat-1.eu/pages/contact.php |
| Description: |
The goal of the 5-year SEURAT-1 Research Initiative ('Towards the replacement of in vivo repeated dose systemic toxicity testing') was to develop a consistent research strategy ready for implementation in following research programmes. This includes establishing innovative scientific tools for better understanding of repeated dose toxicity based on in vitro tests, and identifies gaps of knowledge to be bridged by future research work. The end result would be testing methods which, within the framework of safety assessment, have a higher predictive value, are faster and cheaper than those currently used, and significantly reduce the use of animal tests. |
| Category: | Research Program/Project/Grant |
| Channel: | Face-to-face - Website - Audio / Video - Social media - Printed |
| Audience: | Scientists - Industry - Researchers - Regulators |
| User access: | Open access |
| Updating frequency: | 2015 |
| Relevance: | Replacement |
| Purpose: | Regulatory testing - Toxicological and safety evaluation - Method development - Education and training - Documentation and information |
| Legislative framework: | Cosmetics Regulation (EC) No 1223/2009 - REACH Regulation (EC) No 1907/2006 |
| Technology/Tools: | Alternative test methods (in vitro) - Non-testing methods (in silico) - Stem cells - Omics - Integrated approaches to testing and assessment (IATA) - High throughput screening - High content screening - Analytics |
Fant du det du lette etter?
Ja, jeg fant det! Nei, jeg fant det ikke!Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.
Kontakt oss gjerne på e-post hvis du har spørsmål.